These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10198275)
1. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone. Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA Toxicol Appl Pharmacol; 1999 Apr; 156(2):106-12. PubMed ID: 10198275 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies. Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912 [TBL] [Abstract][Full Text] [Related]
3. Extremely weak tumor-promoting effect of troglitazone on splenic hemangiosarcomas in rasH2 mice induced by urethane. Jin M; Matsumoto S; Dewa Y; Nishimura J; Saekusa Y; Hasumi K; Mitsumori K Arch Toxicol; 2008 Oct; 82(10):771-7. PubMed ID: 18465119 [TBL] [Abstract][Full Text] [Related]
4. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of human hemangiosarcomas and hemangiomas. Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722 [TBL] [Abstract][Full Text] [Related]
6. Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Hong HL; Ton TV; Devereux TR; Moomaw C; Clayton N; Chan P; Dunnick JK; Sills RC Toxicol Appl Pharmacol; 2003 Sep; 191(3):227-34. PubMed ID: 13678655 [TBL] [Abstract][Full Text] [Related]
7. Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Hong HH; Devereux TR; Melnick RL; Moomaw CR; Boorman GA; Sills RC Toxicol Pathol; 2000; 28(4):529-34. PubMed ID: 10930038 [TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice. Kleymenova E; Everitt JI; Pluta L; Portis M; Gnarra JR; Walker CL Carcinogenesis; 2004 Mar; 25(3):309-15. PubMed ID: 14604887 [TBL] [Abstract][Full Text] [Related]
10. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model. Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273 [TBL] [Abstract][Full Text] [Related]
11. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. Chen NG; Han X Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice. Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of vascular urinary bladder tumors from cows with enzootic hematuria. Carvalho T; Naydan D; Nunes T; Pinto C; Peleteiro MC Vet Pathol; 2009 Mar; 46(2):211-21. PubMed ID: 19261631 [TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of expression profiles of hematopoietic stem cell, endothelial cell, and myeloid cell antigens in spontaneous and chemically induced hemangiosarcomas and hemangiomas in mice. Kakiuchi-Kiyota S; Crabbs TA; Arnold LL; Pennington KL; Cook JC; Malarkey DE; Cohen SM Toxicol Pathol; 2013 Jul; 41(5):709-21. PubMed ID: 23125116 [TBL] [Abstract][Full Text] [Related]
17. Endothelial cell tumors. Bell CD Microsc Res Tech; 2003 Feb; 60(2):165-70. PubMed ID: 12539170 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297 [TBL] [Abstract][Full Text] [Related]
19. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657 [TBL] [Abstract][Full Text] [Related]
20. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]